Abivax ABVX
NASDAQ ABVX
$93.49 +0.90 (+0.97%)
At close: Oct 21, 2026 · 4:00 PM EDT

Abivax (ABVX) EBT Margin (2024 - 2026)

Updated

Analysis

Abivax (ABVX) EBT Margin (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 26.66%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 25.18%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -4.11%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 18.19%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 27.53%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -131.41%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -4.34%
10 Abivax 6.50 Bn 4.14 Bn - -272.40%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -272.40%
Sep 30, 2025 -159.07%
Jun 30, 2025 -867.95%
Mar 31, 2025 -2,430.16%
Dec 31, 2024 -4,541.87%
Sep 30, 2024 -528.13%
Jun 30, 2024 -415.41%
Mar 31, 2024 -633.94%
API Access

Abivax EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ABVX&period=max&api_key=YOUR_API_KEY